Latest return on equity
Sonoma Pharmaceuticals Return on equity
Direct answer
Sonoma Pharmaceuticals's return on equity is -42.52%.
The verified market snapshot reports -42.52%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -42.52%
Explore related company data
View Sonoma Pharmaceuticals's market capitalizationView Sonoma Pharmaceuticals's price-to-book ratioView Sonoma Pharmaceuticals's dividend yieldView Sonoma Pharmaceuticals's 52-week price rangeView Sonoma Pharmaceuticals's revenue growthView Sonoma Pharmaceuticals's profit marginView Sonoma Pharmaceuticals's debt-to-equity ratioView all Sonoma Pharmaceuticals key metricsReturn to Sonoma Pharmaceuticals profile